(Q38302045)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25544707%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

review article

1 reference

title

The HER2 Signaling Network in Breast Cancer--Like a Spider in its Web (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25544707%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25544707%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

author name string

A Dittrich

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25544707%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

D Browell

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25544707%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

A Tyson-Capper

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25544707%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

publication date

28 December 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25544707%20AND%20SRC:MED&resulttype=core&format=json

Journal of Mammary Gland Biology and Neoplasia

26 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25544707%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25544707%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

issue

3-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25544707%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

page(s)

253-270

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25544707%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10911-014-9329-5

26 February 2020

exact match

0 references

cites work

The role of HER2 in cancer therapy and targeted drug delivery

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Current approaches and future directions in the treatment of HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Untangling the ErbB signalling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Effects of the EGFR/HER2 kinase inhibitor GW572016 on EGFR- and HER2-overexpressing breast cancer cell line proliferation, radiosensitization, and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Transactivation of erbB2 by short and long isoforms of leptin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Bidirectional Crosstalk between the Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 Signaling Pathways in Breast Cancer: Molecular Basis and Clinical Implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Estrogen receptor β agonists affect growth and gene expression of human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

A feedback loop between androgen receptor and ERK signaling in estrogen receptor-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

A functionally significant cross-talk between androgen receptor and ErbB2 pathways in estrogen receptor negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Progesterone receptor induces ErbB-2 nuclear translocation to promote breast cancer growth via a novel transcriptional effect: ErbB-2 function as a coactivator of Stat3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Cyclooxygenase-2 predicts adverse effects of tamoxifen: a possible mechanism of role for nuclear HER2 in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Identification of HTF (HER2 transcription factor) as an AP-2 (activator protein-2) transcription factor and contribution of the HTF binding site to ERBB2 gene overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

An EGR2/CITED1 transcription factor complex and the 14-3-3sigma tumor suppressor are involved in regulating ErbB2 expression in a transgenic-mouse model of human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

A novel cis-acting element in Her2 promoter regulated by Stat3 in mammary cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Negative transcriptional control of ERBB2 gene by MBP-1 and HDAC1: diagnostic implications in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Myc promoter-binding protein-1 (MBP-1) is a novel potential prognostic marker in invasive ductal breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Clinical Significance of HER-2 Splice Variants in Breast Cancer Progression and Drug Resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

In vivo identification of the interaction site of ErbB2 extracellular domain with its autoinhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

The human splice variant Δ16HER2 induces rapid tumor onset in a reporter transgenic mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

An oncogenic isoform of HER2 associated with locally disseminated breast cancer and trastuzumab resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Role of exon-16-deleted HER2 in breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Destabilization of ERBB2 transcripts by targeting 3' untranslated region messenger RNA associated HuR and histone deacetylase-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Preliminary validation of ERBB2 expression regulated by miR-548d-3p and miR-559.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

miR-331-3p regulates ERBB-2 expression and androgen receptor signaling in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

A naturally occurring HER2 carboxy-terminal fragment promotes mammary tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Truncated p110 ERBB2 induces mammary epithelial cell migration, invasion and orthotopic xenograft formation, and is associated with loss of phosphorylated STAT5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab-resistant tumors and suppress their growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

HER2 shedding and serum HER2 extracellular domain: biology and clinical utility in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/Neu

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Understanding the HER family in breast cancer: interaction with ligands, dimerization and treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Emerging roles of ADAM and ADAMTS metalloproteinases in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Regulated ADAM17-dependent EGF family ligand release by substrate-selecting signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Identification of prolidase as a high affinity ligand of the ErbB2 receptor and its regulation of ErbB2 signaling and cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

SRC-3Delta4 mediates the interaction of EGFR with FAK to promote cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

FAK integrates growth-factor and integrin signals to promote cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

EGFR/MEK/ERK/CDK5-dependent integrin-independent FAK phosphorylated on serine 732 contributes to microtubule depolymerization and mitosis in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Activation of c-Src/HER1/STAT5b and HER1/ERK1/2 signaling pathways and cell migration by hexachlorobenzene in MDA-MB-231 human breast cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-γ1 signalling in breast cancer cell migration and dissemination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

HER2 stabilizes EGFR and itself by altering autophosphorylation patterns in a manner that overcomes regulatory mechanisms and promotes proliferative and transformation signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Leptin augments proliferation of breast cancer cells via transactivation of HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Leptin/HER2 crosstalk in breast cancer: in vitro study and preliminary in vivo analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Mucin-based targeted pancreatic cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Breast cancer stem cells: a novel therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Cyclin D1 inhibits hepatic lipogenesis via repression of carbohydrate response element binding protein and hepatocyte nuclear factor 4α.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Temporal profiling of lapatinib-suppressed phosphorylation signals in EGFR/HER2 pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

PI3K and cancer: lessons, challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Signal transduction and the Ets family of transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Activation of the neu tyrosine kinase induces the fos/jun transcription factor complex, the glucose transporter and ornithine decarboxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

MNK1 and MNK2 regulation in HER2-overexpressing breast cancer lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Nuclear localization and regulation of erk- and rsk-encoded protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Regulation and function of the RSK family of protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Signal-dependent Elk-1 target genes involved in transcript processing and cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Cell signaling by receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

The E2F transcriptional network: old acquaintances with new faces

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

The E2F1-3 transcription factors are essential for cellular proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Control of the p53-p21CIP1 Axis by E2f1, E2f2, and E2f3 is essential for G1/S progression and cellular transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

PI3K/Akt signalling pathway and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

FOXO1A is a target for HER2-overexpressing breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Anti-HER3 domain 1 and 3 antibodies reduce tumor growth by hindering HER2/HER3 dimerization and AKT-induced MDM2, XIAP, and FoxO1 phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Trastuzumab-resistant cells rely on a HER2-PI3K-FoxO-survivin axis and are sensitive to PI3K inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

HER2 stabilizes survivin while concomitantly down-regulating survivin gene transcription by suppressing Notch cleavage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

mTORC1 signalling and mRNA translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

S6 kinase 2 promotes breast cancer cell survival via Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Glycogen synthase kinase 3: more than a namesake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

EMT, the cytoskeleton, and cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Selective hormone-dependent repression of estrogen receptor beta by a p38-activated ErbB2/ErbB3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

The potential role of ER beta isoforms in the clinical management of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Targeting insulin-like growth factor in breast cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Retracted: Targeting 3-Phosphoinoside-Dependent Kinase-1 to Inhibit Insulin-Like Growth Factor-I Induced AKT and p70 S6 Kinase Activation in Breast Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

HER receptor signaling confers resistance to the insulin-like growth factor-I receptor inhibitor, BMS-536924.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Heterotrimerization of the growth factor receptors erbB2, erbB3, and insulin-like growth factor-i receptor in breast cancer cells resistant to herceptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Transcriptional profiling of ErbB signalling in mammary luminal epithelial cells--interplay of ErbB and IGF1 signalling through IGFBP3 regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Protein tyrosine phosphatases in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Protein-tyrosine phosphatase PTPN9 negatively regulates ErbB2 and epidermal growth factor receptor signaling in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

ErbB2, EphrinB1, Src kinase and PTPN13 signaling complex regulates MAP kinase signaling in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Expression of the putative tumor suppressor gene PTPN13/PTPL1 is an independent prognostic marker for overall survival in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Activation of Src by protein tyrosine phosphatase 1B Is required for ErbB2 transformation of human breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

PTP1B expression is an independent positive prognostic factor in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Receptor protein-tyrosine phosphatase α regulates focal adhesion kinase phosphorylation and ErbB2 oncoprotein-mediated mammary epithelial cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

TGF-β: duality of function between tumor prevention and carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

HER2/Neu (ErbB2) signaling to Rac1-Pak1 is temporally and spatially modulated by transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Transforming growth factor beta induces clustering of HER2 and integrins by activating Src-focal adhesion kinase and receptor association to the cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

p21-activated protein kinase: a crucial component of morphological signaling?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Mammary epithelial cell: influence of extracellular matrix composition and organization during development and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

The tumor suppressor function of STAT1 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Tyrosine phosphorylation regulates the partitioning of STAT1 between different dimer conformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Stat1 is a suppressor of ErbB2/Neu-mediated cellular transformation and mouse mammary gland tumor formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

STAT1 gene expression is enhanced by nuclear EGFR and HER2 via cooperation with STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Heregulinbeta activates store-operated Ca2+ channels through c-erbB2 receptor level-dependent pathway in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Calmodulin binds HER2 and modulates HER2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

The ErbB2/Neu/HER2 receptor is a new calmodulin-binding protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

S100A14, a member of the EF-hand calcium-binding proteins, is overexpressed in breast cancer and acts as a modulator of HER2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

The Na+/H+ exchanger NHE1, but not the Na+, HCO3(-) cotransporter NBCn1, regulates motility of MCF7 breast cancer cells expressing constitutively active ErbB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Nuclear translocation and functions of growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Triple-negative breast cancer: epidemiological considerations and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Breast cancer as a systemic disease: a view of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Neoadjuvant chemotherapy and targeted therapy in breast cancer: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

The combined immunodetection of AP-2alpha and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Capture and identification of proteins that bind to a GGA-rich sequence from the ERBB2 gene promoter region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Phosphoproteomic analysis of Her2/neu signaling and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-014-9329-5

Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity

21 January 2018

1 reference

12 December 2020

AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice

1 reference

12 December 2020

The AKT genes and their roles in various disorders

1 reference

12 December 2020

HER2 aberrations in cancer: implications for therapy

1 reference

12 December 2020

Stat1 negatively regulates angiogenesis, tumorigenicity and metastasis of tumor cells

1 reference

12 December 2020

The ErbB/HER family of protein-tyrosine kinases and cancer

1 reference

12 December 2020

Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer.

1 reference

12 December 2020

PEA3 cooperates with c-Jun in regulation of HER2/neu transcription.

1 reference

12 December 2020

Expression of FOXO1 is associated with GATA3 and Annexin-1 and predicts disease-free survival in breast cancer

1 reference

12 December 2020

NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: role of PI3 kinase and p38 MAP kinase pathways

1 reference

12 December 2020

MUC1 cytoplasmic domain coactivates Wnt target gene transcription and confers transformation

1 reference

12 December 2020

Selective roles of E2Fs for ErbB2- and Myc-mediated mammary tumorigenesis

1 reference

12 December 2020

Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation

1 reference

12 December 2020

Akt phosphorylates and activates HSF-1 independent of heat shock, leading to Slug overexpression and epithelial-mesenchymal transition (EMT) of HER2-overexpressing breast cancer cells

1 reference

12 December 2020

ErbB2 upregulates the Na+,HCO3(-)-cotransporter NBCn1/SLC4A7 in human breast cancer cells via Akt, ERK, Src, and Kruppel-like factor 4.

1 reference

12 December 2020

Protein tyrosine phosphatases as novel targets in breast cancer therapy.

1 reference

12 December 2020

Estrogen receptor (ER) beta1 and ERbetacx/beta2 inhibit ERalpha function differently in breast cancer cell line MCF7

1 reference

12 December 2020

Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expression

1 reference

12 December 2020

Phosphoinositide 3-kinase is activated by phosphopeptides that bind to the SH2 domains of the 85-kDa subunit

1 reference

12 December 2020

PTEN function: the long and the short of it.

1 reference

12 December 2020

ErbB3-binding protein EBP1 decreases ErbB2 levels via a transcriptional mechanism

1 reference

12 December 2020

Heregulin targets gamma-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 oncoprotein

1 reference

12 December 2020

Feedback regulation of mitogen-activated protein kinase kinase kinase activity of c-Raf-1 by insulin and phorbol ester stimulation

1 reference

12 December 2020

Induction of heat shock proteins by heregulin beta1 leads to protection from apoptosis and anchorage-independent growth.

1 reference

12 December 2020

Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy

1 reference

12 December 2020

Hyperactivation of MAPK induces loss of ERalpha expression in breast cancer cells

1 reference

12 December 2020